Financials

News Ideas Technicals Forecast

KNSA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Kiniksa Pharmaceuticals, Ltd.

Total assets of KNSA for Q4 23 is 526.32 M USD, 8.96% more than the previous Q3 23. And total liabilities increased by 12.25% in Q4 23 to 87.48 M USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—